Biogen: Argus Research raises rating to buy from hold
BIIB•Argus Research raised its rating on Biogen to buy from hold.
Related News
H2O America launches $325 million remarketable senior note offering
HTO•
Insperity Q3 adjusted EPS jumps on reduced compensation costs
NSP•
Corvus Pharmaceuticals to report third-quarter financial results
CRVS•
Incyte raises 2026 net sales forecast to $5.21 billion-$5.3 billion
INCY•
Intellia to present four-year lonvo-z data in hereditary angioedema at ACAAI 2026
NTLA•